Carmen Adriaens-Turner, Ph.D.

Carmen Adriaens-Turner, Ph.D. has a diverse work experience in the field of molecular biology and cancer research. Carmen is currently working as a Sr. Scientist in Discovery Biology at DEM Biopharma, Inc. Prior to this, they were a Scientist II in Genome Engineering at SQZ Biotechnologies, where they focused on developing cell therapies against cancer and other diseases using Genome Engineering. Carmen also facilitated collaborations with other companies and provided training sessions for scientists using Cell Squeeze Technology.

Before joining SQZ Biotechnologies, Carmen worked as a Research Fellow at the Dana-Farber Cancer Institute. Carmen'sresearch focused on studying chromatin dynamics in melanoma cancer cells upon interferon signaling. Carmen utilized Genome Engineering techniques and microscopy-based and Next-Generation Sequencing-based approaches to visualize nuclear components and pathways in cells. Carmen'sfindings primarily revolved around the histone methyl-transferase enzyme SETDB1 and global chromatin changes upon interferon stimulation.

Carmen has also held positions as a Postdoctoral Researcher at both the Broad Institute of MIT and Harvard and Harvard Medical School and Massachusetts General Hospital. At the Broad Institute, they studied chromatin architecture and nuclear compartmentalization in cancer cells. Carmen organized seminars and presented ongoing projects. At Mass General Hospital, they focused on gene regulation and nuclear organization using high-resolution microscopy and Next-Generation Sequencing-based approaches.

During their Ph.D. training at VIB, Carmen worked as a Graduate Researcher in the Laboratory for Molecular Cancer Biology. Carmen also had research stays as a Visiting Research Fellow at the National Cancer Institute (NCI) and the Gurdon Institute. Additionally, they had internships at the Laboratory for Molecular Cancer Biology and iNSERM 1035, Laboratory of biotherapies for genetic diseases and Cancer.

Carmen Adriaens-Turner, Ph.D. has a strong background in molecular biology and a broad range of experience in cancer research, with expertise in chromatin dynamics, gene regulation, and genome engineering.

Carmen Adriaens-Turner, Ph.D. has a strong education background in the field of biomedical sciences and oncology. From 2014 to 2019, they pursued a Doctor of Philosophy (PhD) degree at both the Faculteit Geneeskunde KU Leuven Faculty of Medicine and VIB, focusing on oncology and cancer biology. Prior to their doctoral studies, they completed a Master of Science (MS) degree in Cell/Cellular and Molecular Biology at KU Leuven from 2012 to 2014. Moreover, they briefly attended Université de Bordeaux in 2012-2013 to pursue a Master of Science (MSc) in Pathophysiology and Neurobiology.

To complement their academic achievements, Carmen Adriaens-Turner has also obtained several certifications. In 2014, they obtained the FELASA B certification from the Federation of European Laboratory Animal Science Associations. Later in 2017, they acquired the FELASA C certification from the same institution, further affirming their expertise in laboratory animal science. In 2020, they completed the Certified Peer Reviewer Course offered by Elsevier.

Overall, Carmen Adriaens-Turner, Ph.D. possesses a rich educational background in the field of biomedical sciences and oncology, accompanied by valuable certifications that enhance their knowledge and skills in their specialized area.